Open Access<p>Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis – A Systematic Literature Review</p>
Author(s) -
Karin Luttropp,
Johan Dalén,
Axel Svedbom,
Mary Dozier,
Chris Black,
Amy Puenpatom
Publication year - 2020
Publication title -
patient preference and adherence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 48
ISSN - 1177-889X
DOI - 10.2147/ppa.s238843
Subject(s) - medicine , ulcerative colitis , discontinuation , medline , systematic review , infliximab , intensive care medicine , disease , political science , law
To obtain an up-to-date overview of the measurement of patient experience of switching biologic treatment in patients with inflammatory arthritis (IA) or ulcerative colitis (UC). Secondary objectives included summarizing the types of patient-reported outcomes (PROs) used (if any), and related findings; and summarizing medical and non-medical reasons for treatment switch and/or discontinuation.